Henry Schein | HSIC - Selling And Administration Expenses

Stock Price
72.73
Daily Change
0.12 0.17%
Monthly
-5.80%
Yearly
0.94%
Q2 Forecast
69.35

Henry Schein reported $809M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Align Technology USD 465.34M 23.67M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Cardinal Health USD 1.51B 6M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cigna USD 3.32B 291M Mar/2026
Concord Medical Services Hldg CNY 140.37M 36.24M Jun/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Encompass Health USD 58.2M 10.2M Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Idexx Laboratories USD 299.85M 24.18M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Laboratory Of America USD 551M 12.4M Mar/2026
McKesson USD 1.8B 234M Mar/2026
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Owens Minor USD 258.98M 7.5M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Stryker USD 2.15B 17M Mar/2026
Tenet Healthcare USD 2.22B 2.12B Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Universal Health Services USD 426.54M 3.78M Mar/2026
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 394M 153.99M Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026
Zoetis USD 588M 31M Mar/2026